The high MAP2K7 protein expression observed in CRC tissues may promote JNK phosphorylation and activation, supporting tumor progression, as also indicated by previous studies on MAP2K7-mediated oncogenic signaling [9,18]. The gene discussed is MAP2K7; the disease is neoplasm.